Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Harpoon Therapeutics, Inc. (HARP)  
$0.89 0.00 (0.00%) as of 4:30 Fri 9/1


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 32,670,000
Market Cap: 29.20(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.546 - $1.06
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Harpoon Therapeutics is a clinical-stage immunotherapy company. Co.'s Tri-specific T cell Activating Construct (TriTACs) product candidates include: HPN328, which is for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors; HPN217, which is for the treatment of multiple myeloma; and HPN536, which is for the treatment of ovarian and pancreatic cancers and other mesothelin- expressing solid tumors. Co.'s proprietary TriTAC product candidate is HPN601, which targets the epithelial cell adhesion molecule and is being developed for the treatment of multiple solid tumor indications.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 21,397,205 24,484,205 24,484,205 24,494,205
Total Buy Value $492,135,715 $492,135,715 $492,135,715 $502,135,715
Total People Bought 1 3 3 3
Total Buy Transactions 1 4 4 5
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 45
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Lathi Vijay K 10% Owner   –       –       •   2023-03-23 3 IO $0.00 $0 I/I 0 2,242,839 9%     
   Lathi Vijay K 10% Owner   –       –       •   2023-03-23 3 IO $0.00 $0 D/D 0 913,860 9%     
   Lathi Vijay K 10% Owner   –       –       •   2023-03-23 3 IO $0.00 $0 D/D 0 10,000 9%     
   Hunt Ronald Director   –       •       •   2023-03-23 4 B $1,000.00 $10,000,000 I/I 10,000 10,000 2.25 9%     
   Lanza Frank J Principal Fin. & Acctng Ofc.Of   •       –      –    2022-09-15 3 IO $0.00 $0 D/D 0 6,540 -27%     
   Erbez Georgia Chief Financial Officer   •       –      –    2021-09-22 4 B $8.10 $83,430 I/I 10,300 19,215 1.99 -39%     
   Wesche Holger Chief Scientific Officer   •       –      –    2021-07-01 4 AS $14.00 $140,000 D/D (10,000) 52,852 -51%     
   Wesche Holger Chief Scientific Officer   •       –      –    2021-07-01 4 OE $0.60 $6,000 D/D 10,000 62,852     -
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-06-02 4 AS $20.50 $514,919 I/I (25,118) 6,328,095 -67%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-06-01 4 AS $20.44 $377,956 I/I (18,491) 6,353,213 -65%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-28 4 AS $20.88 $293,315 I/I (13,885) 6,371,704 -65%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-27 4 AS $20.26 $282,850 I/I (13,961) 6,385,589 -63%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-26 4 AS $20.04 $64,088 I/I (3,198) 6,399,550 -63%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-24 4 AS $20.12 $100,600 I/I (5,000) 6,402,748 -59%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-21 4 AS $20.21 $220,430 I/I (10,907) 6,407,748 -61%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-20 4 AS $20.34 $238,242 I/I (11,713) 6,418,655 -61%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-19 4 AS $20.39 $363,615 I/I (17,833) 6,430,368 -60%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-18 4 AS $20.67 $380,369 I/I (18,402) 6,448,201 -61%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-17 4 AS $20.07 $93,647 I/I (4,666) 6,466,603 -60%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-14 4 AS $20.04 $138,276 I/I (6,900) 6,471,269 -57%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-13 4 AS $20.06 $97,391 I/I (4,855) 6,478,169 -59%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-12 4 AS $20.53 $609,413 I/I (29,684) 6,483,024 -58%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-11 4 AS $20.96 $453,707 I/I (21,445) 6,512,708 -59%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-10 4 AS $21.78 $373,436 I/I (17,133) 6,534,153 -60%     
   Ubs Oncology Impact Fund L.p. 10% Owner   –       –       •   2021-05-05 4 AS $22.52 $229,107 I/I (10,172) 6,551,286 -62%     

  45 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed